Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
7.
Int J Gynaecol Obstet ; 138 Suppl 1: 4-6, 2017 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-28691327

RESUMEN

The outlook for elimination of the scourge of cervical cancer is bright, because we now have the tools to achieve this goal. In recent years human papillomavirus (HPV) vaccination in high-income countries has resulted in dramatic decreases in HPV infection and associated cervical disease. If all countries with a substantial burden of disease introduce the vaccine nationally, we can protect the vast majority of women and girls most at risk. For women who are beyond the vaccination target age, progress has been made in screening and treatment for cervical precancer, but we must accelerate this momentum to reduce incidence and mortality worldwide to the very low rates found in wealthier countries. Human and financial resources must be increased and directed to programs that follow best practices and reach all women, including the marginalized or disadvantaged. Seven key actions are recommended. Now is the time for action at national, regional, and global levels.


Asunto(s)
Vacunación Masiva , Infecciones por Papillomavirus/prevención & control , Vacunas contra Papillomavirus/provisión & distribución , Neoplasias del Cuello Uterino/prevención & control , Femenino , Salud Global , Implementación de Plan de Salud , Humanos , Salud de la Mujer
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA